Literature DB >> 22727280

Vitrectorhexis and lens aspiration with posterior chamber intraocular lens implantation in spherophakia.

Christiane Al-Haddad1, Lama Khatib.   

Abstract

UNLABELLED: We describe a technique that uses the vitrector to perform successful lens aspiration and posterior chamber intraocular lens (IOL) implantation in children with spherophakia and anterior lens subluxation. After an anterior chamber maintainer is placed, the ocutome is introduced through a limbal incision to perform a circular vitrectorhexis to avoid excessive manipulation of the unstable lens followed by gentle cortex aspiration. A foldable IOL is injected into the sulcus (3-piece IOL) or bag (1-piece IOL) if the capsule is sufficiently stable. Through a pars plana incision, the ocutome is then used to perform a posterior capsulotomy to prevent late posterior capsule opacification. In our patient, sulcus IOL placement was more stable than in-the-bag placement. FINANCIAL DISCLOSURE: Neither author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2012 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727280     DOI: 10.1016/j.jcrs.2012.05.001

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Management of Traumatic Cataract with Posterior Capsular Rupture: A Case Report and In Vitro Model Study.

Authors:  Wenjuan Wan; Ke Hu; Yan Ji; Can Li
Journal:  Case Rep Ophthalmol Med       Date:  2017-07-18

2.  Retropupillary iris-claw intraocular lens for the surgical correction of aphakia in cases with microspherophakia.

Authors:  Sameh Mosaad Fouda; Mahmoud A Al Aswad; Basem M Ibrahim; Ashraf Bori; Hala K Mattout
Journal:  Indian J Ophthalmol       Date:  2016-12       Impact factor: 1.848

3.  Scleral-fixated intraocular lens implantation in microspherophakia.

Authors:  Sujata Subbiah; Philip A Thomas; C A Nelson Jesudasan
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.